Cingulate Inc (CING)

Currency in USD
7.510
-0.530(-6.59%)
Closed·
Unusual trading volume
CING is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6.9008.200
52 wk Range
3.20011.890
Key Statistics
Prev. Close
8.04
Open
8.05
Day's Range
6.9-8.2
52 wk Range
3.2-11.89
Volume
1.07M
Average Volume (3m)
423.29K
1-Year Change
97.6264%
Book Value / Share
0.37
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CING Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
27.772
Upside
+269.80%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings downwards for the upcoming period

Cingulate Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company’s lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.

Compare CING to Peers and Sector

Metrics to compare
CING
Peers
Sector
Relationship
P/E Ratio
−3.5x−2.2x−0.5x
PEG Ratio
−0.07−0.040.00
Price/Book
31.2x1.6x2.6x
Price / LTM Sales
-1.1x3.2x
Upside (Analyst Target)
171.9%193.9%53.4%
Fair Value Upside
Unlock26.9%7.7%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 27.772
(+269.80% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Ascendiant Capital
Buy62.00+725.57%61.00Maintain22/08/2025
Ascendiant Capital
Buy61.00+712.25%60.00Maintain27/05/2025
Ascendiant Capital
Buy60.00+698.93%75.00Maintain21/04/2025

Earnings

Latest Release
13/11/2025
EPS / Forecast
-1.35 / -0.95
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

0.201
LIMN
-5.19%
0.256
BRTX
+11.79%
23.56
EVMN
-2.20%
0.3561
MGRX
-4.33%

FAQ

What Is the Cingulate (CING) Share Price Today?

The Cingulate stock price today is 7.510 USD.

What Stock Exchange Does Cingulate (CING) Trade On?

Cingulate is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Cingulate?

The stock symbol (also called a 'ticker') for Cingulate is "CING."

What Is the Current Cingulate Market Cap?

As of today, Cingulate market cap is 83.760M USD.

What Is Cingulate's (CING) Earnings Per Share (TTM)?

The Cingulate EPS is currently -4.440 (Trailing Twelve Months).

Is CING a Buy or Sell From a Technical Analyst Perspective?

Based on today's Cingulate moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Cingulate Stock Split?

Cingulate has split 2 times. (See the CING stock split history page for full effective split date and price information.)

How Many Employees Does Cingulate Have?

Cingulate has 13 employees.

What is the current trading status of Cingulate (CING)?

As of 19/03/2026, Cingulate (CING) is trading at a price of 7.510 USD, with a previous close of 8.040 USD. The stock has fluctuated within a day range of 6.900 USD to 8.200 USD, while its 52-week range spans from 3.200 USD to 11.890 USD.

What Is Cingulate (CING) Price Target According to Analysts?

The average 12-month price target for Cingulate is 27.772 USD, with a high estimate of 58 USD and a low estimate of 8 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +269.80% Upside potential.

What Is the CING Premarket Price?

CING's last pre-market stock price is 8.099 USD. The pre-market share volume is 47,090.000, and the stock has decreased by 0.059, or 0.740%.

What Is the CING After Hours Price?

CING's last after hours stock price is 8.010 USD, the stock has decreased by -0.030, or -0.370%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.